|Immunogen||Human RSV Isolate, Confirmed|
|Purification||IgG fraction covalently coupled to a highly purified preparation of Horseradish Peroxidase (RZ >3). Care is taken to ensure adequate conjugation while preserving maximum enzyme activity. Free enzyme is removed.|
|Target/Specificity||All RSV viral antigens. Reacts well with bovine isolates. Does not react with Para 1-3, Influenza A & B or Adenovirus by IFA. Negative against HEp-2 cells and WI-38 cells.|
|Storage||Short-term (up to 6 months) store at 2-8°C. Long term, aliquot and store at -20°C. Avoid multiple freeze/thaw cycles.|
|Precautions||Goat Antibody to Respiratory Syncytial Virus (RSV) Horseradish Peroxidase Conjugated is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The references listed below are for research purposes only:1. McLellan, J.S., et al., (2010), “Structure of a more antigenic site on the Respiratory Syncytial Virus fusion glycoprotein in complex with neutralizing antibody 101F, Journal of Virology, 84(23): 12236-12244.2. Bitko, V., et al., (2007), “Nonstructural Proteins of Respiratory Syncytial Virus Suppress Premature Apoptosis by an NF-kB-Dependent, Interferon-Independent Mechanism and Facilitate Virus Growth”, Journal of Virology, 81(4): 1786-1795.3. Weltzin, R., et al., (1994), “Intranasal Monoclonal Immunoglobulin A against Respiratory Syncytial Virus Protects against Upper and Lower Respiratory Tract Infections in Mice”, Antimicrobial Agents and Chemotherapy, 38(12): 2785-2791.4. Ramaswamy, M., et al., (2004), “Specific Inhibition of Type I Interferon Signal Transduction by Respiratory Syncytial Virus”, Am. J. Respir. Cell Mol. Biol., 30: 893-900.5. Gitiban, N., et al., (2005), “Chinchilla and Murine Models of Upper Respiratory Tract Infections with Respiratory Syncytial Virus”, Journal of Virology, 79(10): 6035-6042.6. Wright, P.F., et al., (2005), “Growth of Respiratory Syncytial Virus in Primary Epithelial Cells from the Human Respiratory Tract”, Journal of Virology, 79(13): 8651-8654.7. Monick, MM., et al., (2001), “Respiratory Syncytial Virus Infection Results in Activation of Multiple Protein Kinase C Isoforms Leading to Activation of Mitogen-Activated Protein Kinase”, The Journal of Immunology, 166: 2681-2687.8. Monick, MM., et al., (2005), “Activation of the Epidermal Growth Factor Receptor by Respiratory Syncytial Virus Results in Increased Inflammation and Delayed Apoptosis”, The Journal of Biological Chemistry”, 280(3): 2147-2158.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.